Inclusion Criteria:
  1. Evidence of a personally signed and dated informed consent document indicating that the participant (or a legal representative) has been informed of all pertinent aspects of the study.
  2. In a child aged ≥7 years (South Africa) or aged ≥8 years (Uganda), evidence of assent to participate
  3. Participants who are willing and able to comply with scheduled visits, laboratory tests, and other study procedures.
  4. HIV-infected, receiving ATV-based ART treatment OR HIV-infected receiving second-line ART with concurrent rifamycin-based TB treatment
  5. Participant is within one of the target populations:
       1. Pregnant (>20 weeks)
       2. Body mass index >30 or <18.5 Kg/m2
       3. Child or adolescent aged <18 years
Exclusion Criteria:
  1. Medical, psychiatric or obstetric condition that might affect participation in the stuy based on investigator judgement
  2. Dissent from a minor
  3. For pregnant women in Uganda, where the husband is reasonably involved, paternal objection